Skip to content
healthcare.dev

ALENDRONATE SODIUM

NDC 69097-223, Alendronate sodium, tablet, from Cipla USA Inc..

Product NDC
69097-223
Status
Listed
Labeler
Cipla USA Inc.
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA076768
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/69097-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ALENDRONATE SODIUM35 mg/1

Pharmacologic classes

Bisphosphonate [EPC]; Diphosphonates [CS]

Package NDCNDC-11Package
69097-223-16690970223161 BLISTER PACK in 1 CARTON (69097-223-16) / 4 TABLET in 1 BLISTER PACK
69097-223-76690970223763 BLISTER PACK in 1 CARTON (69097-223-76) / 4 TABLET in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/e2fac28d-ad91-4cdc-a003-9fdeac073f76
  • NADAC price for package 69097022316

    GET /v1/drugs/nadac/69097022316
  • NADAC price for package 69097022376

    GET /v1/drugs/nadac/69097022376

Use it

Look up 69097-223 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/69097-223 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 69097-223. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.